Why Caesars’ Digital Arm May Be the Gaming Giant’s Best-Kept Secret
It’s not often that a company with the scale and…
Sell
12
CRVS Quote, Financials, Valuation and Earnings
Last price:
$5.04
Seasonality move
:
-9.57%
Day range:
$4.73 - $5.34
52-week range:
$1.30 - $10.00
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
--
P/B ratio:
25.89x
Volume:
2.6M
Avg. volume:
1.4M
1-year change:
220.51%
Market cap:
$321.3M
Revenue:
--
EPS (TTM):
-$0.92
| Period Ending | 2019-12-31 | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | |
|---|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- | |
| Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
| Cost of Revenues | -- | -- | -- | -- | -- | |
| Gross Profit | -- | -- | -- | -- | -- | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | $38M | $31.8M | $29.1M | $24.5M | $16.5M | |
| Selling, General & Admin | $10.9M | $11.9M | $9.5M | $8.1M | $6.9M | |
| Other Inc / (Exp) | -- | $37.2M | -$4.6M | -$9.4M | -$5.2M | |
| Operating Expenses | $48.9M | $43.8M | $38.6M | $32.6M | $23.4M | |
| Operating Income | -$48.9M | -$43.8M | -$38.6M | -$32.6M | -$23.4M | |
| Net Interest Expenses | -- | -- | -- | -- | -- | |
| EBT. Incl. Unusual Items | -$46.7M | -$6M | -$43.2M | -$41.3M | -$27M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | -- | -- | -- | -- | -- | |
| Net Income to Company | -$46.7M | -$6M | -$43.2M | -$41.3M | -$27M | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | -$46.7M | -$6M | -$43.2M | -$41.3M | -$27M | |
| Basic EPS (Cont. Ops) | -$1.59 | -$0.20 | -$1.03 | -$0.89 | -$0.56 | |
| Diluted EPS (Cont. Ops) | -$1.59 | -$0.20 | -$1.03 | -$0.89 | -$0.56 | |
| Weighted Average Basic Share | $29.3M | $29.5M | $41.9M | $46.6M | $48M | |
| Weighted Average Diluted Share | $29.3M | $29.5M | $41.9M | $46.6M | $48M | |
| EBITDA | -$48.1M | -$43.1M | -$38.2M | -$32.2M | -$23.3M | |
| EBIT | -$48.9M | -$43.8M | -$38.6M | -$32.6M | -$23.4M | |
| Revenue (Reported) | -- | -- | -- | -- | -- | |
| Operating Income (Reported) | -$48.9M | -$43.8M | -$38.6M | -$32.6M | -$23.4M | |
| Operating Income (Adjusted) | -$48.9M | -$43.8M | -$38.6M | -$32.6M | -$23.4M | |
| Period Ending | 2020-09-30 | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | |
|---|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- | |
| Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
| Cost of Revenues | -- | -- | -- | -- | -- | |
| Gross Profit | -- | -- | -- | -- | -- | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | $6.6M | $7M | $10.4M | $4M | $5.2M | |
| Selling, General & Admin | $3.2M | $2.1M | $2.1M | $1.6M | $2M | |
| Other Inc / (Exp) | -- | -$1.6M | -$2.6M | -$865K | -$33.5M | |
| Operating Expenses | $9.8M | $9M | $12.5M | $5.6M | $7.3M | |
| Operating Income | -$9.8M | -$9M | -$12.5M | -$5.6M | -$7.3M | |
| Net Interest Expenses | -- | -- | -- | -- | -- | |
| EBT. Incl. Unusual Items | -$9.8M | -$10.7M | -$14.8M | -$6M | -$40.2M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | -- | -- | -- | -- | -- | |
| Net Income to Company | -$9.8M | -$10.7M | -$14.8M | -$6M | -$40.2M | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | -$9.8M | -$10.7M | -$14.8M | -$6M | -$40.2M | |
| Basic EPS (Cont. Ops) | -$0.33 | -$0.24 | -$0.32 | -$0.12 | -$0.60 | |
| Diluted EPS (Cont. Ops) | -$0.33 | -$0.24 | -$0.32 | -$0.12 | -$0.60 | |
| Weighted Average Basic Share | $29.5M | $43.9M | $46.6M | $49M | $66.7M | |
| Weighted Average Diluted Share | $29.5M | $43.9M | $46.6M | $49M | $66.7M | |
| EBITDA | -$9.7M | -$10.6M | -$12.4M | -$5.5M | -$7.2M | |
| EBIT | -$9.8M | -$10.7M | -$12.5M | -$5.6M | -$7.3M | |
| Revenue (Reported) | -- | -- | -- | -- | -- | |
| Operating Income (Reported) | -$9.8M | -$9M | -$12.5M | -$5.6M | -$7.3M | |
| Operating Income (Adjusted) | -$9.8M | -$10.7M | -$12.5M | -$5.6M | -$7.3M | |
| Period Ending | 2020-09-30 | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | |
|---|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- | |
| Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
| Cost of Revenues | -- | -- | -- | -- | -- | |
| Gross Profit | -- | -- | -- | -- | -- | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | $33.6M | $31.5M | $25.2M | $16.6M | $17.4M | |
| Selling, General & Admin | $11.8M | $10.2M | $8.5M | $6.8M | $7.7M | |
| Other Inc / (Exp) | -- | -$2.4M | -$7.3M | -$8.3M | -$33.4M | |
| Operating Expenses | $45.3M | $41.7M | $33.7M | $23.4M | $25.1M | |
| Operating Income | -$45.3M | -$41.7M | -$33.7M | -$23.4M | -$25.1M | |
| Net Interest Expenses | -- | -- | -- | -- | -- | |
| EBT. Incl. Unusual Items | -$44.4M | -$6.7M | -$40.7M | -$30.2M | -$56.8M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | -- | -- | -- | -- | -- | |
| Net Income to Company | -$44.4M | -$6.7M | -$40.7M | -$30.2M | -$56.8M | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | -$44.4M | -$6.7M | -$40.7M | -$30.2M | -$56.8M | |
| Basic EPS (Cont. Ops) | -$1.51 | $0.06 | -$0.88 | -$0.64 | -$0.92 | |
| Diluted EPS (Cont. Ops) | -$1.51 | $0.06 | -$0.88 | -$0.64 | -$0.92 | |
| Weighted Average Basic Share | -- | -- | -- | -- | -- | |
| Weighted Average Diluted Share | -- | -- | -- | -- | -- | |
| EBITDA | -$44.6M | -$42.8M | -$31.2M | -$23.2M | -$25M | |
| EBIT | -$45.3M | -$43.3M | -$31.5M | -$23.4M | -$25.1M | |
| Revenue (Reported) | -- | -- | -- | -- | -- | |
| Operating Income (Reported) | -$45.3M | -$41.7M | -$33.7M | -$23.4M | -$25.1M | |
| Operating Income (Adjusted) | -$45.3M | -$43.3M | -$31.5M | -$23.4M | -$25.1M | |
| Period Ending | 2020-09-30 | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | |
|---|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- | |
| Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
| Cost of Revenues | -- | -- | -- | -- | -- | |
| Gross Profit | -- | -- | -- | -- | -- | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | $24.6M | $24.3M | $20.4M | $12.5M | $13.4M | |
| Selling, General & Admin | $9.2M | $7.5M | $6.5M | $5.2M | $6M | |
| Other Inc / (Exp) | -- | -$2.2M | -$4.9M | -$3.8M | -$32.1M | |
| Operating Expenses | $33.9M | $31.8M | $26.9M | $17.8M | $19.4M | |
| Operating Income | -$33.9M | -$31.8M | -$26.9M | -$17.8M | -$19.4M | |
| Net Interest Expenses | -- | -- | -- | -- | -- | |
| EBT. Incl. Unusual Items | -$33.3M | -$34M | -$31.5M | -$20.4M | -$50.2M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | -- | -- | -- | -- | -- | |
| Net Income to Company | -$33.3M | -$34M | -$31.5M | -$20.4M | -$50.2M | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | -$33.3M | -$34M | -$31.5M | -$20.4M | -$50.2M | |
| Basic EPS (Cont. Ops) | -$1.13 | -$0.86 | -$0.68 | -$0.43 | -$0.79 | |
| Diluted EPS (Cont. Ops) | -$1.13 | -$0.86 | -$0.68 | -$0.43 | -$0.79 | |
| Weighted Average Basic Share | $88.3M | $120.7M | $139.7M | $143M | $175.4M | |
| Weighted Average Diluted Share | $88.3M | $120.7M | $139.7M | $143M | $175.4M | |
| EBITDA | -$33.4M | -$33.1M | -$26.6M | -$17.6M | -$19.4M | |
| EBIT | -$33.9M | -$33.4M | -$26.9M | -$17.8M | -$19.4M | |
| Revenue (Reported) | -- | -- | -- | -- | -- | |
| Operating Income (Reported) | -$33.9M | -$31.8M | -$26.9M | -$17.8M | -$19.4M | |
| Operating Income (Adjusted) | -$33.9M | -$33.4M | -$26.9M | -$17.8M | -$19.4M | |
| Period Ending | 2019-12-31 | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | |
|---|---|---|---|---|---|---|
| Cash and Equivalents | $5.2M | $16.5M | $63.5M | $13.2M | $12.6M | |
| Short Term Investments | $72.8M | $27.8M | $6M | $29.1M | $14.5M | |
| Accounts Receivable, Net | -- | -- | $507K | $588K | $26K | |
| Inventory | -- | -- | -- | -- | -- | |
| Prepaid Expenses | $547K | $585K | $1.2M | $626K | $524K | |
| Other Current Assets | $486K | $406K | $128K | $102K | $220K | |
| Total Current Assets | $79.3M | $45.3M | $71.3M | $43.7M | $28M | |
| Property Plant And Equipment | $3.8M | $2.6M | $3.6M | $2.6M | $1.4M | |
| Long-Term Investments | -- | $37.2M | $34.3M | $21.9M | $16.1M | |
| Goodwill | -- | -- | -- | -- | -- | |
| Other Intangibles | -- | -- | -- | -- | -- | |
| Other Long-Term Assets | $513K | $414K | $236K | $129K | $89K | |
| Total Assets | $83.6M | $85.5M | $109.5M | $68.2M | $45.6M | |
| Accounts Payable | $2.4M | $3.5M | $1.6M | $2M | $1.5M | |
| Accrued Expenses | $5.3M | $5.2M | $5.1M | $6.3M | $3M | |
| Current Portion Of Long-Term Debt | -- | -- | -- | -- | -- | |
| Current Portion Of Capital Lease Obligations | $878K | $1.1M | $1M | $1.2M | $1.4M | |
| Other Current Liabilities | -- | $180K | $121K | $158K | $245K | |
| Total Current Liabilities | $10.2M | $12.1M | $9.7M | $10.8M | $6.9M | |
| Long-Term Debt | -- | -- | -- | -- | -- | |
| Capital Leases | -- | -- | -- | -- | -- | |
| Total Liabilities | $12.5M | $13.4M | $12.3M | $12.1M | $6.9M | |
| Common Stock | $3K | $3K | $5K | $5K | $5K | |
| Other Common Equity Adj | $29K | $4K | $1.9M | -$563K | -$967K | |
| Common Equity | $71.1M | $72.1M | $97.2M | $56.1M | $38.7M | |
| Total Preferred Equity | -- | -- | -- | -- | -- | |
| Minority Interest, Total | -- | -- | -- | -- | -- | |
| Total Equity | $71.1M | $72.1M | $97.2M | $56.1M | $38.7M | |
| Total Liabilities and Equity | $83.6M | $85.5M | $109.5M | $68.2M | $45.6M | |
| Cash and Short Terms | $78M | $44.3M | $69.5M | $42.3M | $27.1M | |
| Total Debt | -- | -- | -- | -- | -- | |
| Period Ending | 2020-09-30 | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | |
|---|---|---|---|---|---|---|
| Cash and Equivalents | $23M | $72.3M | $24.6M | $20.1M | $4.7M | |
| Short Term Investments | $28.4M | $4M | $25M | $12.1M | $37M | |
| Accounts Receivable, Net | -- | $276K | $503K | $11K | $70K | |
| Inventory | -- | -- | -- | -- | -- | |
| Prepaid Expenses | $561K | $2M | $724K | $662K | $416K | |
| Other Current Assets | $448K | $98K | $397K | $214K | $633K | |
| Total Current Assets | $52.5M | $78.8M | $51.3M | $33.1M | $42.9M | |
| Property Plant And Equipment | $2.9M | $4M | $2.9M | $1.7M | $455K | |
| Long-Term Investments | -- | $36.3M | $25.9M | $17.1M | $15.2M | |
| Goodwill | -- | -- | -- | -- | -- | |
| Other Intangibles | -- | -- | -- | -- | -- | |
| Other Long-Term Assets | $480K | $279K | $248K | $89K | $252K | |
| Total Assets | $55.9M | $119.3M | $80.3M | $51.9M | $58.8M | |
| Accounts Payable | $2.6M | $2.3M | $4.2M | $1.4M | $1.9M | |
| Accrued Expenses | $6.1M | $6.4M | $7.1M | $3.5M | $3.2M | |
| Current Portion Of Long-Term Debt | -- | -- | -- | -- | -- | |
| Current Portion Of Capital Lease Obligations | $1M | $1M | $1.2M | $1.3M | $354K | |
| Other Current Liabilities | -- | $130K | $176K | $262K | $40.4M | |
| Total Current Liabilities | $12M | $11.3M | $14M | $7.3M | $46.4M | |
| Long-Term Debt | -- | -- | -- | -- | -- | |
| Capital Leases | -- | -- | -- | -- | -- | |
| Total Liabilities | $13.5M | $14.2M | $15.7M | $7.7M | $46.4M | |
| Common Stock | $3K | $5K | $5K | $5K | $6K | |
| Other Common Equity Adj | $12K | $1.4M | -$1.2M | -$1.4M | -$738K | |
| Common Equity | -- | -- | -- | -- | -- | |
| Total Preferred Equity | -- | -- | -- | -- | -- | |
| Minority Interest, Total | -- | -- | -- | -- | -- | |
| Total Equity | $42.4M | $105.1M | $64.7M | $44.3M | $12.4M | |
| Total Liabilities and Equity | $55.9M | $119.3M | $80.3M | $51.9M | $58.8M | |
| Cash and Short Terms | $51.4M | $76.3M | $49.6M | $32.2M | $41.7M | |
| Total Debt | -- | -- | -- | -- | -- | |
| Period Ending | 2019-12-31 | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | -$46.7M | -$6M | -$43.2M | -$41.3M | -$27M | |
| Depreciation & Amoritzation | $743K | $632K | $460K | $367K | $151K | |
| Stock-Based Compensation | $7.3M | $5.7M | $4.2M | $2.7M | $2.1M | |
| Change in Accounts Receivable | -- | -- | -$507K | -$81K | $562K | |
| Change in Inventories | -- | -- | -- | -- | -- | |
| Cash From Operations | -$37.3M | -$34.8M | -$36.7M | -$27M | -$23.9M | |
| Capital Expenditures | -- | -- | -- | -- | -- | |
| Cash Acquisitions | -- | -- | -- | -- | -- | |
| Cash From Investing | $3.3M | $44.8M | $21.6M | -$23.3M | $15.5M | |
| Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
| Special Dividend Paid | ||||||
| Long-Term Debt Issued | -- | -- | -- | -- | -- | |
| Long-Term Debt Repaid | -- | -- | -- | -- | -- | |
| Repurchase of Common Stock | -- | -- | -- | -- | -- | |
| Other Financing Activities | -- | -- | -- | -- | -- | |
| Cash From Financing | $24K | $1.3M | $62.2M | -- | $7.9M | |
| Beginning Cash (CF) | $39.2M | $5.2M | $16.5M | $63.5M | $13.2M | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | -$34M | $11.3M | $47M | -$50.3M | -$539K | |
| Ending Cash (CF) | $5.2M | $16.5M | $63.5M | $13.2M | $12.6M | |
| Levered Free Cash Flow | -$37.3M | -$34.9M | -$36.7M | -$27.3M | -$24M | |
| Period Ending | 2020-09-30 | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | -$9.8M | -$10.7M | -$14.8M | -$6M | -$40.2M | |
| Depreciation & Amoritzation | $147K | $108K | $94K | $30K | $21K | |
| Stock-Based Compensation | $1.3M | $1.1M | $658K | $546K | $733K | |
| Change in Accounts Receivable | -- | -$273K | -$130K | -$11K | -$35K | |
| Change in Inventories | -- | -- | -- | -- | -- | |
| Cash From Operations | -$7.7M | -$8.4M | -$6.9M | -$5.4M | -$6.3M | |
| Capital Expenditures | -- | -- | -- | -- | -- | |
| Cash Acquisitions | -- | -- | -- | -- | -- | |
| Cash From Investing | $9.9M | $3.5M | $3M | $17.5M | -$3.9M | |
| Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
| Special Dividend Paid | -- | -- | -- | -- | -- | |
| Long-Term Debt Issued | -- | -- | -- | -- | -- | |
| Long-Term Debt Repaid | -- | -- | -- | -- | -- | |
| Repurchase of Common Stock | -- | -- | -- | -- | -- | |
| Other Financing Activities | -- | -- | -- | -- | -- | |
| Cash From Financing | $64K | $18.3M | -- | $335K | $50K | |
| Beginning Cash (CF) | $20.7M | $58.9M | $28.5M | $7.7M | $14.8M | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | $2.3M | $13.4M | -$3.9M | $12.4M | -$10.2M | |
| Ending Cash (CF) | $23M | $72.3M | $24.6M | $20.1M | $4.7M | |
| Levered Free Cash Flow | -$7.8M | -$8.4M | -$7.2M | -$5.4M | -$6.3M | |
| Period Ending | 2020-09-30 | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | -$44.4M | -$6.7M | -$40.7M | -$30.2M | -$56.8M | |
| Depreciation & Amoritzation | $675K | $509K | $366K | $217K | $93K | |
| Stock-Based Compensation | $6.3M | $4.7M | $2.8M | $2.2M | $2.8M | |
| Change in Accounts Receivable | -- | -$276K | -$227K | $492K | -$59K | |
| Change in Inventories | -- | -- | -- | -- | -- | |
| Cash From Operations | -$35.1M | -$38.1M | -$26.3M | -$26.3M | -$22.1M | |
| Capital Expenditures | -- | -- | -- | -- | -- | |
| Cash Acquisitions | -- | -- | -- | -- | -- | |
| Cash From Investing | $48.9M | $24M | -$21.4M | $14M | -$23.7M | |
| Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
| Special Dividend Paid | ||||||
| Long-Term Debt Issued | -- | -- | -- | -- | -- | |
| Long-Term Debt Repaid | -- | -- | -- | -- | -- | |
| Repurchase of Common Stock | -- | -- | -- | -- | -- | |
| Other Financing Activities | -- | -- | -- | -- | -- | |
| Cash From Financing | $89K | $63.4M | $18K | $7.9M | $30.4M | |
| Beginning Cash (CF) | -- | -- | -- | -- | -- | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | $13.9M | $49.3M | -$47.7M | -$4.5M | -$15.4M | |
| Ending Cash (CF) | -- | -- | -- | -- | -- | |
| Levered Free Cash Flow | -$35.2M | -$38.1M | -$26.6M | -$26.3M | -$22.1M | |
| Period Ending | 2020-09-30 | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | -$33.3M | -$34M | -$31.5M | -$20.4M | -$50.2M | |
| Depreciation & Amoritzation | $490K | $367K | $273K | $123K | $65K | |
| Stock-Based Compensation | $4.5M | $3.5M | $2.1M | $1.6M | $2.2M | |
| Change in Accounts Receivable | -- | -$276K | $4K | $577K | -$44K | |
| Change in Inventories | -- | -- | -- | -- | -- | |
| Cash From Operations | -$26.6M | -$29.9M | -$19.5M | -$18.8M | -$17M | |
| Capital Expenditures | -- | -- | -- | -- | -- | |
| Cash Acquisitions | -- | -- | -- | -- | -- | |
| Cash From Investing | $44.3M | $23.6M | -$19.4M | $17.9M | -$21.4M | |
| Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
| Special Dividend Paid | -- | -- | -- | -- | -- | |
| Long-Term Debt Issued | -- | -- | -- | -- | -- | |
| Long-Term Debt Repaid | -- | -- | -- | -- | -- | |
| Repurchase of Common Stock | -- | -- | -- | -- | -- | |
| Other Financing Activities | -- | -- | -- | -- | -- | |
| Cash From Financing | $87K | $62.1M | -- | $7.9M | $30.4M | |
| Beginning Cash (CF) | $49.4M | $120.5M | $123.4M | $30.5M | $34.9M | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | $17.8M | $55.8M | -$38.9M | $6.9M | -$7.9M | |
| Ending Cash (CF) | $67.2M | $176.3M | $84.5M | $37.4M | $27M | |
| Levered Free Cash Flow | -$26.6M | -$29.9M | -$19.7M | -$18.8M | -$17M | |
Get CRVS Stock Alert
Signup to receive the latest stock alerts
Financial Ratios
CRVS
Sector
P/E ratio
--
25.86x
PEG ratio
--
0.00x
P/B ratio
25.89x
1.85x
Price / LTM sales
--
1.86x
Growth Metrics
CRVS
Sector
Revenue growth
--
7.28%
Earnings growth
--
1.82%
Revenue (5-year growth)
--
8.73%
Earnings forecast
-$0.12
-$0.20
Profitability
CRVS
Sector
Profitability FY 2024
--
$57.1M
Return on invested capital
--
-14.06%
Return on assets
--
-11.77%
Return on equity
--
-14.78%
Earnings Date
Last Earnings Date
Nov
12
Next Earnings Date
Mar
19
Estimated Next Earnings Date
Feb
11
Balance Sheet
CRVS
Sector
Total cash
$41.7M
$47M
Short term investments
$14.5M
$45.2M
Total assets
$45.6M
$142.6M
Long term debt
--
$6.5M
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Will Tyson Foods Stock Bounce Back?
Tyson Foods, Inc. (NYSE:TSN) is one of the biggest food…
Will Iovance Biotherapeutics Stock Bounce Back?
Iovance Biotherapeutics (NASDAQ:IOVA) is a fledgling pharmaceutical company that specializes…
Stock Ideas
Buy
64
Is AAPL Stock a Buy?
Market Cap: $3.8T
P/E Ratio: 42x
Buy
52
Is NVDA Stock a Buy?
Market Cap: $3.3T
P/E Ratio: 113x
Buy
55
Is MSFT Stock a Buy?
Market Cap: $3.2T
P/E Ratio: 37x
Alerts
Buy
61
QMCO alert for Dec 21
Quantum [QMCO] is up 26.28% over the past day.
Sell
46
NUKK alert for Dec 21
Nukkleus [NUKK] is down 22.94% over the past day.
Sell
1
IIPR alert for Dec 21
Innovative Industrial Properties [IIPR] is down 22.7% over the past day.
THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS
Show me the best stock
